Dana Investment Advisors Inc. boosted its holdings in shares of Zoetis Inc (NYSE:ZTS) by 2.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 84,317 shares of the company’s stock after purchasing an additional 2,226 shares during the period. Dana Investment Advisors Inc.’s holdings in Zoetis were worth $5,376,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of ZTS. Janus Henderson Group PLC lifted its position in Zoetis by 7,717.4% during the second quarter. Janus Henderson Group PLC now owns 5,809,086 shares of the company’s stock valued at $362,372,000 after purchasing an additional 5,734,776 shares during the period. Alliancebernstein L.P. increased its holdings in Zoetis by 55.4% in the second quarter. Alliancebernstein L.P. now owns 10,370,388 shares of the company’s stock valued at $646,905,000 after buying an additional 3,695,449 shares in the last quarter. BlackRock Inc. increased its holdings in Zoetis by 3.9% in the second quarter. BlackRock Inc. now owns 37,495,299 shares of the company’s stock valued at $2,338,957,000 after buying an additional 1,412,829 shares in the last quarter. AJO LP increased its holdings in Zoetis by 4,506.8% in the second quarter. AJO LP now owns 1,271,425 shares of the company’s stock valued at $79,311,000 after buying an additional 1,243,826 shares in the last quarter. Finally, Thrivent Financial For Lutherans increased its holdings in Zoetis by 642.7% in the second quarter. Thrivent Financial For Lutherans now owns 1,336,033 shares of the company’s stock valued at $83,342,000 after buying an additional 1,156,142 shares in the last quarter. Institutional investors own 93.33% of the company’s stock.
A number of research analysts have weighed in on the stock. Cantor Fitzgerald set a $80.00 price objective on shares of Zoetis and gave the company a “buy” rating in a report on Tuesday. Morgan Stanley raised shares of Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 price objective for the company in a report on Wednesday, November 29th. UBS reaffirmed a “neutral” rating on shares of Zoetis in a report on Friday, November 24th. Cowen set a $80.00 target price on shares of Zoetis and gave the stock a “buy” rating in a research note on Friday, November 17th. Finally, Jefferies Group reissued a “buy” rating on shares of Zoetis in a research note on Friday, November 10th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $68.53.
Shares of Zoetis Inc (NYSE ZTS) traded up $0.15 during midday trading on Thursday, reaching $72.38. 1,595,000 shares of the company traded hands, compared to its average volume of 2,752,414. Zoetis Inc has a one year low of $50.57 and a one year high of $72.99. The stock has a market cap of $35,270.00, a PE ratio of 33.13, a PEG ratio of 2.17 and a beta of 1.06. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80.
Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.02. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter in the prior year, the company earned $0.52 EPS. Zoetis’s revenue was up 8.5% compared to the same quarter last year. research analysts anticipate that Zoetis Inc will post 2.37 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be paid a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.70%. The ex-dividend date of this dividend is Thursday, January 18th. This is a boost from Zoetis’s previous quarterly dividend of $0.11. Zoetis’s dividend payout ratio is currently 22.11%.
COPYRIGHT VIOLATION NOTICE: “Dana Investment Advisors Inc. Boosts Position in Zoetis Inc (ZTS)” was first reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://www.thelincolnianonline.com/2017/12/14/dana-investment-advisors-inc-boosts-position-in-zoetis-inc-zts.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.